Epigenetic therapy shows promise against treatment-resistant AML

Researchers astatine The University of Texas MD Anderson Cancer Center person discovered that an investigational epigenetic therapy remained effectual successful treatment-resistant acute myeloid leukemia (AML) by activating the Hippo pathway, a tumor-suppressing pathway linked to crab maturation and cause resistance.